02/04/2025
NOLCA – the Nordic Liver Cancer Association
Webinar
28 April 2025, 16:00–17:00 CET
Optimal use of the ToolboX for HCC treatment
Time Topic Speaker
16:00 Welcome, house order, and introduction Pia Österlund (FI/S)
16:05 16:20 16:25 Case #1: “Transplantation or ablation.
Or: Too early to consider transplantation?”
Per Stål (S)
Case #2: “Downstaging to transplantation.
Or: Too advanced to consider transplantation?”
Aki Uutela (FI)
“Immunotherapy in the setting of liver transplantation –
mission (im)possible?”
Ghassan Abou-Alfa (US)
16:45 Discussion Moderator: Pia Österlund
16:59 Thank you and goodbye Pia Österlund
Learning goals:
• Understanding of the management of HCC patients on the fringe of transplant eligibility.
• Be aware of the challenges with immunotherapy in the liver transplant setting.
Click here to register for the webinar!
Registration is mandatory to join the webinar. You can also register through the NOLCA website.
Take the opportunity to become a NOLCA member—it’s free! Go to www.nolca.eu and press
“become a member” on the front page. Thank you.
And don’t forget the NOLCA annual meeting in Helsinki, 18–19 September, 2025.
This webinar is supported by:
AstraZeneca and Eisai have had no influence on content of the
agenda, nor speakers. The content is the property of the
speakers. NOLCA and speakers are fully responsible for the
medical and scientific content of the webinar.
More details to come, but already now you can mark the dates September 18-19, 2025 in your calendars. UpcomingWebinar on April 28details and registration hereConference and General Assembly HelsinikiSeptember 18 - 19, 2025
